Company / Gross Margin
Zomedica Corp. Gross Margin History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
67.7%
FY2025
5-year range
67.7% / 71.2%
FY2022-FY2025
Trend
-3.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Margin remained relatively stable over the past 4 years, with values between 67.7% and 71.2%.
Based on SEC 10-K filings.
67.7% in FY2025 with a 3-year CAGR of -3.5%.
Remained stable around 67.7% over the past 2 years.
Gross Margin over time
Growth rates
- 3-Year Change
- -3.5pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, gross margin decreased 3.2% year-over-year.
Company context
Key Data Points
- Altman Z-Score 0.66 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 67.7% | -3.2% |
| FY2024 | 70.0% | +1.7% |
| FY2023 | 68.8% | -3.4% |
| FY2022 | 71.2% | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026